While these features may be attributed to NF1, the atypical progression of lesions on imaging, combined with new enhancing demyelinating lesions and corroborative CSF findings (positive oligoclonal bands and elevated IgG index), led to a definitive diagnosis of MS. The gene discussed is NF1; the disease is myeloid sarcoma.